Helicobacter pylori gastritis: a connective disease;La gastrite à Helicobacter pylori, une pathologie frontière

Revue de Medecine Interne

Volumn 27, Issue SUPPL. 2, 2006, Pages

  de Korwin, J D ^a  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

Author keywords

[No Author keywords available]

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT;

ARTICLE; BACTERIAL INFECTION; BACTERIAL TRANSMISSION; DISEASE COURSE; GASTRITIS; GASTROESOPHAGEAL REFLUX; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HUMAN; PREVALENCE; MICROBIOLOGY; REVIEW;

GASTRITIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS;

EID: 33747399341     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2006.03.021     Document Type: Article

References (27)

1. Conclusions et recommandations révisées du Groupe de travail. Conférence de consensus Helicobacter pylori -- révision 1999. Gastroenterol. Clin. Biol. 23 (1999) C95-C104
2. Malfertheiner P., Mégraud F., O'Morain C., Hungin A.P.S., Jones R., Axon D.Y., et al. Current concepts in the management of Helicobacter pylori infection. The Maastricht 2000 Consensus Report. Aliment. Pharmacol. Ther. 16 (2002) 167-180
3. De Korwin JD, Lozniewski A. Helicobacter pylori : notions fondamentales et perspectives. Encycl Med Chir, Gastroentérologie, 9-000-B-60, 2000, 8p.
4. Kuipers E.J., and Michetti P. Bacteria and mucosal inflammation of the gut: lessons from Helicobacter pylori. Helicobacter 10 Suppl 1 (2005) 66-70
5. Israel D.A., and Peek Jr. R.M. The role of persistence in Helicobacter pylori pathogenesis. Curr. Opin. Gastroenterol. 22 1 (2006) 3-7
6. De Korwin JD, Frédéric M. Les gastrites chroniques. EMC Gastro-entérologie 2003, 9-017-A-10.
7. Huang J.Q., Sridhar S., and Hunt R. Role of Helicobacter pylori infection and non-steroidal anti-inflammatory drugs in peptic ulcer disease: a meta-analysis. Lancet 359 (2002) 14-22
8. Ford A.C., Forman D., Bailey A.G., Axon A.T., and Moayyedi P. A community screening program for Helicobacter pylori saves money: 10-year follow-up of a randomized controlled trial. Gastroenterology 129 (2005) 1910-1917
9. Moayyedi P., Deeks J., Talley N.J., Delaney B., and Forman D. An update of the Cochrane Systematic Review of Helicobacter pylori eradication therapy in nonulcer dyspepsia: resolving the discrepancy between systematic reviews. Am. J. Gastroenterol. 98 (2003) 2621-2626
10. Laine L., and Sugg J. Effect of Helicobacter pylori eradication on development of erosive esophagitis and gastroesophageal reflux disease symptoms: a post hoc analysis of eight double blind prospective studies. Am. J. Gastroenterol. 97 (2002) 2992-2997
11. Moayyedi P., Bardhan C., Young L., Dixon M.F., Brown L., and Axon A.T.R. Helicobacter pylori eradication does not exacerbate reflux symptoms in gastroesophageal reflux disease. Gastroenterology 121 (2001) 1120-1126
12. Annibale B., Capurso G., Lahner E., Passi S., Ricci R., Maggio F., et al. Concomitant alterations in intragastric pH and ascorbic acid concentration in patients with Helicobacter pylori gastritis and associated iron deficiency anaemia. Gut 52 (2003) 496-501
13. Peek Jr. R.M., and Crabtree J.E. Helicobacter infection and gastric neoplasia. J. Pathol. 208 (2006) 233-248
14. De Korwin J.D. Infection et lymphomes du MALT. Quoi de neuf?. Rev. Med. Interne 25 (2004) 545-547
15. Wundisch T., Thiede C., Morgner A., Dempfle A., Gunther A., Liu H., et al. Long-term follow-up of gastric MALT lymphoma after Helicobacter pylori eradication. J. Clin. Oncol. 23 (2005) 8018-8024
16. Chen L.T., Lin J.T., Tai J.J., Chen G.H., Yeh H.Z., Yang S.S., et al. Long-term results of anti-Helicobacter pylori therapy in early-stage gastric high-grade transformed MALT lymphoma. J. Natl. Cancer Inst. 97 (2005) 1345-1353
17. Ando T., Goto Y., Maeda O., Watanabe O., Ishiguro K., and Goto H. Causal role of Helicobacter pylori infection in gastric cancer. World J. Gastroenterol. 12 (2006) 181-186
18. Uemura N., Okamoto S., Yamamoto S., Matsumura N., Yamaguchi S., Yamakido M., et al. Helicobacter pylori infection and the development of gastric cancer. N. Engl. J. Med. 345 (2001) 784-789
19. Guarner J., Herrera-Goepfert R., Mohar A., Smith C., Schofield A., Halperin D., et al. Diagnostic yield of gastric biopsy specimens when screening for preneoplastic lesions. Hum. Pathol. 34 (2003) 28-31
20. Vaananen H., Vauhkonen M., Helske T., Kaariainen I., Rasmussen M., Tunturi-Hihnala H., et al. Non-endoscopic diagnosis of atrophic gastritis with a blood test. Correlation between gastric histology and serum levels of gastrin-17 and pepsinogen I: a multicentre study. Eur. J. Gastroenterol. Hepatol. 15 (2003) 885-891
21. Wong B.C., Lam S.K., Wong W.M., Chen J.S., Zheng T.T., Feng R.E., et al. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA 291 (2004) 187-194
22. Malfertheiner P., Sipponen P., Naumann M., Moayyedi P., Megraud F., Xiao S.D., et al. Helicobacter pylori eradication has the potential to prevent gastric cancer: a state-of-the-art critique. Am. J. Gastroenterol. 100 (2005) 2100-2115
23. Federman D.G., Kirsner R.S., Moriarty J.P., and Concato J. The effect of antibiotic therapy for patients infected with Helicobacter pylori who have chronic urticaria. J. Am. Acad. Dermatol. 49 (2003) 861-864
24. Ridker P.M., Danesh J., Youngman L., Collins R., Stampfer M.J., Peto R., et al. A prospective study of Helicobacter pylori seropositivity and the risk for future myocardial infarction among socioeconomically similar U.S. men. Ann. Intern. Med. 135 (2001) 184-188
25. Preusch M.R., Grau J.A., Buggle F., Lichy C., Bartel J., Black C., et al. Association between cerebral ischemia and Cytotoxin-associated gene-A-bearing strains of Helicobacter pylori. Stroke 35 (2004) 1800
26. Franchini M., and Veneri D. Helicobacter pylori infection and immune thrombocytopenic purpura: an update. Helicobacter 9 (2004) 342-346
27. Takahashi T., Yujiri T., Shinohara K., Inoue Y., Sato Y., Fujii Y., et al. Molecular mimicry by Helicobacter pylori CagA protein may be involved in the pathogenesis of H. pylori-associated chronic idiopathic thrombocytopenic purpura. Br. J. Haematol. 124 (2004) 91-96